Ronald S. Swerdloff
Los Angeles Biomedical Research Institute
450 Papers
5.7K Citations
Ronald S. Swerdloff is an academic researcher from Los Angeles Biomedical Research Institute. The author has contributed to research in topics: Testosterone (patch) & Medicine. The author has an hindex of 91, co-authored 430 publications. Previous affiliations of Ronald S. Swerdloff include City of Hope National Medical Center & Lithuanian University of Health Sciences.
Chat about Author
Papers
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.
Shalender Bhasin,Glenn R. Cunningham,Frances J. Hayes,Alvin M. Matsumoto,Peter J. Snyder,Ronald S. Swerdloff,Victor M. Montori +6 more
TL;DR: The guidelines for the evaluation and treatment of androgen deficiency syndromes in adult men published previously in 2006 were updated by the Task Force of the Clinical Guidelines Subcommittee of The Endocrine Society.
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline
Shalender Bhasin,Juan P. Brito,Glenn R. Cunningham,Frances J. Hayes,Howard N. Hodis,Alvin M. Matsumoto,Peter J. Snyder,Ronald S. Swerdloff,Frederick C. W. Wu,Maria A Yialamas +9 more
TL;DR: It is suggested that when clinicians institute T therapy, they aim at achieving T concentrations in the mid-normal range during treatment with any of the approved formulations, taking into consideration patient preference, pharmacokinetics, formulation-specific adverse effects, treatment burden, and cost.
1.2K
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations
Cong-Yi Wang,Eberhard Nieschlag,Ronald S. Swerdloff,Hermann M. Behre,Wayne Jg Hellstrom,Louis Gooren,Jean-Marc Kaufman,Jean-Jacques Legros,Bruno Lunenfeld,Alvaro Morales,John E. Morley,Claude Schulman,Ian M. Thompson,Wolfgang Weidner,Frederick C. W. Wu +14 more
TL;DR: In this paper, the effects of androgen treatment of hypogonadal men on multiple target organs and the recent studies show short-term beneficial effects of testosterone in older men that are similar to those in younger men.
Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men
Christina Wang,Ronald S. Swerdloff,Ali Iranmanesh,Adrian S. Dobs,Peter J. Snyder,Glenn R. Cunningham,Alvin M. Matsumoto,Thomas Weber,Nancy Berman +8 more
TL;DR: It is concluded that T gel replacement improved sexual function and mood, increased lean mass and muscle strength (principally in the legs), and decreased fat mass in hypogonadal men with less skin irritation and discontinuation compared with the recommended dose of the permeation-enhanced T patch.
914
Effects of Testosterone Treatment in Older Men
Peter J. Snyder,Shalender Bhasin,Glenn R. Cunningham,Alvin M. Matsumoto,Alisa J. Stephens-Shields,J. A. Cauley,Thomas M. Gill,Elizabeth Barrett-Connor,Ronald S. Swerdloff,Ronald S. Swerdloff,Christina Wang,Christina Wang,Kristine E. Ensrud,Cora E. Lewis,John T. Farrar,David Cella,Raymond C. Rosen,Marco Pahor,Jill P. Crandall,Mark E. Molitch,Denise Cifelli,Darlene Dougar,Laura Fluharty,Susan M. Resnick,Thomas W. Storer,Stephen D. Anton,Shehzad Basaria,Susan J. Diem,X. Hou,Emile R. Mohler,J. K. Parsons,Nanette K. Wenger,Bret Zeldow,J. R. Landis,Susan S. Ellenberg +34 more
TL;DR: In symptomatic men 65 years of age or older, raising testosterone concentrations for 1 year from moderately low to the mid-normal range for men 19 to 40 years ofAge had a moderate benefit with respect to sexual function and some benefit withrespect to mood and depressive symptoms but no benefit with Respect to vitality or walking distance.
741